These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Nitrate tolerance in angina therapy. How to avoid it. Rutherford JD Drugs; 1995 Feb; 49(2):196-9. PubMed ID: 7729327 [TBL] [Abstract][Full Text] [Related]
44. Risk of rebound phenomenon during nitrate withdrawal. Ferratini M Int J Cardiol; 1994 Jun; 45(2):89-96. PubMed ID: 7960258 [TBL] [Abstract][Full Text] [Related]
45. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate. Aronow S Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537 [TBL] [Abstract][Full Text] [Related]
46. Nitrate therapy for angina pectoris. Current concepts about mechanism of action and evaluation of currently available preparations. Corwin S; Reiffel JA Arch Intern Med; 1985 Mar; 145(3):538-43. PubMed ID: 3919668 [TBL] [Abstract][Full Text] [Related]
47. Isosorbide di-nitrate in angina pectoris. A double-blind-study of 50 cases. Sepaha GC; Jain SR; Chatterji AN; Chandrakar MP Indian Heart J; 1970 Jan; 22(1):17-23. PubMed ID: 5493996 [No Abstract] [Full Text] [Related]
51. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease. Uberbacher HJ; Steinorth G; Glocke M; Abshagen U Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004 [TBL] [Abstract][Full Text] [Related]
52. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris. Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of nitroglycerin in angina in patients on isosorbide dinitrate. Aronow WS; Chesluk HM Circulation; 1970 Jul; 42(1):61-3. PubMed ID: 4987556 [No Abstract] [Full Text] [Related]
54. Medical management of angina pectoris. Kotler MN; Segal BL; Likoff W Postgrad Med; 1977 Mar; 61(3):113-7. PubMed ID: 402651 [TBL] [Abstract][Full Text] [Related]
55. Tolerance to the hemodynamic and antianginal effects of the organic nitrates. Parker JO Z Kardiol; 1985; 74 Suppl 1():45-9. PubMed ID: 3922142 [No Abstract] [Full Text] [Related]
56. Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris. Boesgaard S; Aldershvile J; Poulsen HE Circulation; 1992 Jan; 85(1):143-9. PubMed ID: 1728443 [TBL] [Abstract][Full Text] [Related]
57. Editorial: Nitrates in the prophylactic treatment of angina pectoris. Goldstein RE; Epstein SE Circulation; 1973 Nov; 48(5):917-20. PubMed ID: 4201658 [No Abstract] [Full Text] [Related]
58. Nitrates and angina pectoris. Parker JO Am J Cardiol; 1993 Sep; 72(8):3C-6C; discussion 6C-8C. PubMed ID: 8372799 [TBL] [Abstract][Full Text] [Related]
59. [Avoidance of tolerance development to long term therapy with nitrates through correct dosage]. Blasini R; Reiniger G; Rudolph W Z Kardiol; 1986; 75 Suppl 3():42-9. PubMed ID: 3541418 [TBL] [Abstract][Full Text] [Related]
60. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness? Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]